Page 47 - Fluorescence-guided cancer surgery

Table 1. Patient and tumor characteristics
Characteristic
Age
Body mass index Pathological tumor size (mm)
Clinical Stage
Stage 0 3 13 Stage 1A 13 54 Stage 1B 1 4 Stage 2A 4 17 Stage 2B 2 8 Stage 3C 1 4
Type of operation
Mastectomy 3 13
Wide local excision 21 87
Histological type
In ltrating ductal type 15 63 adenocarcinoma
In ltrating lobular type 4 17 adenocarcinoma
Mucinous adenocarcinoma 1 4
Primary mucoepidermoid 1 4 carcinoma
Ductal carcinoma in situ 3 12 Receptor status
ER positive 19 79 PR positive 11 46 HER2/NEU positive 1 4
Triple Negative 2 8
Histological grade (Bloom-Richardon)
I 5 21 II 9 38 III 4 16 No grading possible 6 25
Early Delayed Imaging Imaging
N=12 N=12
Mean Range Mean Range P
59 (44-82) 60 (46-71) 0.97 24 (19-37) 27 (22-37) 0.16 14 (7-27) 16 (6-33) 0.58
Detection of breast cancer using methylene blue 45
Total N=24
Mean Range
60 (44-82) 24 (19-37) 15 (6-33)
N%N%N%
3 25 7 58 0 0 2 17 0 0 0 0
1 9 11 92
6 50 2 17
1 4 3 25
8 67 6 50 0 0 1 9
1 9 5 42 2 17 4 34
0 0 6 50 1 9 2 17 2 17 1 9
2 17 10 84
9 75 2 17 1 9
0.22
0.54 0.22
11 92 0.83 5 42 0.26 1 9 0.38 1 9 0.95
4 34 4 34 2 17 2 17
0.34